COVID-19

COVID-19: Hydroxychloroquine Results; Ad5 Vectored Vaccine; Dietary Supplement Review

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

2:58 AM (9 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS Hydroxychloroquine or Chloroquine for COVID-19: Large Study Finds No Benefit Evidence Supporting Dietary Supplement Use for COVID-19 Lacking Adenovirus Type 5 Vectored COVID-19 Vaccine Tolerable, Immunogenic in Phase 1 Study Phexxi, a Vaginal pH Regulator, Approved for Pregnancy Prevention Alunbrig Approved as First-Line Treatment for ALK-Positive Metastatic NSCLC COVID-19 Resource Center CME/CE Spotlight Improved Outcomes for Naïve & Heavily Treatment—Experienced HIV Patients AMA PRA Category 1 Credit(s)TM, CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME